Internal Medicine, Endocrinology, Diabetes, & Metabolism · Sun City West, AZ
NPI
1487679668
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
14416 W Meeker Blvd Ste 300
Sun City West, AZ, 85375
Phone (623) 876-6960
Groups this clinician bills Medicare through
Medicare paid, 2024
$667K
26,497 services
Medicare patients, 2024
1,152
Average age 77
Drug cost, 2024
$1.8M
5,422 prescriptions
Company payments, 2024
$13.97
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Harmeet S Narula was code J0897 (injection, denosumab, 1 mg), 21,840 times for 221 patients. In total Harmeet S Narula billed 26,497 services in 11 codes, and Medicare paid $667K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 21,840 | 221 | $20.53 | $448K |
| 99214 Office E&M - Established | Office | 1,442 | 971 | $90.18 | $130K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,439 | 962 | $11.88 | $17K |
| 95251 Test - Miscellaneous | Office | 370 | 222 | $25.59 | $9,469 |
| 96372 Injection Administration | Office | 347 | 216 | $10.13 | $3,516 |
| 99215 Office E&M - Established | Office | 294 | 242 | $126.60 | $37K |
| 99205 Office E&M - New | Office | 88 | 88 | $144.89 | $13K |
| 99204 Office E&M - New | Office | 72 | 72 | $121.91 | $8,778 |
By year: 2022 $489K for 22,814 services; 2023 $541K for 23,473 services; 2024 $667K for 26,497 services.
Medicare prescription drug claims, 2024
In 2024, the drug Harmeet S Narula prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,152 prescriptions and refills. In total Harmeet S Narula wrote 5,422 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,152 | 3,232 | 349 | $12K |
| Ozempic Semaglutide | 397 | 611 | 112 | $575K |
| Metformin Hcl Er Metformin Hcl | 383 | 1,085 | 137 | $4,730 |
| Metformin Hcl Generic | 249 | 697 | 87 | $2,376 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 229 | 578 | 95 | $35K |
| Methimazole Generic | 189 | 527 | 68 | $1,330 |
| Jardiance Empagliflozin | 180 | 342 | 54 | $192K |
| Synthroid Levothyroxine Sodium | 168 | 487 | 52 | $13K |
| Glimepiride Generic | 136 | 400 | 47 | $1,805 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 131 | 364 | 52 | $14K |
| Mounjaro Tirzepatide | 113 | 156 | 34 | $159K |
| Novolog Flexpen Insulin Aspart | 104 | 222 | 35 | $32K |
| Trulicity Dulaglutide | 85 | 144 | 36 | $139K |
| Atorvastatin Calcium Generic | 80 | 239 | 31 | $865 |
| Glipizide Generic | 72 | 204 | 23 | $650 |
Brand drugs: 2,513 claims; generic drugs: 2,498 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Harmeet S Narula $13.97 ($13.97 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbott Laboratories with $13.97.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 1 | $13.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.